AMANDA LAVIN: Open Payments
NPI 1528386489 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,953 in 115 payments from 7 companies in 2025. Trend: 2023 $636 · 2024 $544 · 2025 $1,953
Food & beverage: $1,953
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 70 | $1,103 |
| Axsome Therapeutics, Inc. | 9 | $252 |
| Tonix Medicines, Inc. | 10 | $161 |
| PFIZER INC. | 12 | $142 |
| Impel Pharmaceuticals LLC | 6 | $133 |
| Merz Pharmaceuticals, LLC | 6 | $123 |
| Lundbeck LLC | 2 | $40 |
Products named: QULIPTA, UBRELVY, Symbravo, BOTOX, ZEMBRACE SYMTOUCH, NURTEC ODT, TRUDHESA, Xeomin.
Industry payments across PA — which companies pay providers there.
